WHO issues alert on counterfeit diabetes drug Ozempic | ABS-CBN
ADVERTISEMENT
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
WHO issues alert on counterfeit diabetes drug Ozempic
WHO issues alert on counterfeit diabetes drug Ozempic
This photograph taken on February 23, 2023, in Paris, shows the anti-diabetic medication Ozempic (semaglutide) made by Danish pharmaceutical company Novo Nordisk. Joel Saget, AFP
This photograph taken on February 23, 2023, in Paris, shows the anti-diabetic medication Ozempic (semaglutide) made by Danish pharmaceutical company Novo Nordisk. Joel Saget, AFPMANILA — The World Health Organization (WHO) has issued a medical product alert on "three falsified batches of Ozempic (Semaglutide)," which is a drug for the treatment of hyperglycemia in Type 2 diabetes among adults, adolescents, and children above 12 years of age.
MANILA — The World Health Organization (WHO) has issued a medical product alert on "three falsified batches of Ozempic (Semaglutide)," which is a drug for the treatment of hyperglycemia in Type 2 diabetes among adults, adolescents, and children above 12 years of age.
"This falsified product has been detected in Brazil (October 2023), the United Kingdom of Great Britain and Northern Ireland (October 2023), and the United States of America (December 2023), and was supplied in the regulated supply chain," the agency said.
"This falsified product has been detected in Brazil (October 2023), the United Kingdom of Great Britain and Northern Ireland (October 2023), and the United States of America (December 2023), and was supplied in the regulated supply chain," the agency said.
"The genuine manufacturer of Ozempic (Novo Nordisk) has confirmed that the three products referenced in this Alert are falsified," it added.
"The genuine manufacturer of Ozempic (Novo Nordisk) has confirmed that the three products referenced in this Alert are falsified," it added.
NOT A WEIGHT-LOSS DRUG
Some have reportedly been using Ozempic for weight loss. But manufacturer Novo Nordisk has already stated the drug "may help you lose weight," but "it is not a weight-loss drug".
Some have reportedly been using Ozempic for weight loss. But manufacturer Novo Nordisk has already stated the drug "may help you lose weight," but "it is not a weight-loss drug".
ADVERTISEMENT
The WHO warned of the risks of using the falsified batches of Ozempic.
The WHO warned of the risks of using the falsified batches of Ozempic.
"The use of falsified Ozempic may result in the ineffective treatment of patients due to incorrect dosage, contamination with harmful substances, or use of unknown or substituted ingredients. It may pose other serious risks to health because of its subcutaneous injection administration that could be life-threatening," it said.
"The use of falsified Ozempic may result in the ineffective treatment of patients due to incorrect dosage, contamination with harmful substances, or use of unknown or substituted ingredients. It may pose other serious risks to health because of its subcutaneous injection administration that could be life-threatening," it said.
Healthcare professionals are also advised to "report any incident of adverse effects, lack of effectiveness and suspected falsification."
Healthcare professionals are also advised to "report any incident of adverse effects, lack of effectiveness and suspected falsification."
"If you have any of the affected products, WHO recommends that you do not use them. If you, or someone you know, has or may have used the affected product, or suffered an adverse reaction or unexpected side-effect after use, you are advised to seek immediate medical advice from a healthcare professional," it added.
"If you have any of the affected products, WHO recommends that you do not use them. If you, or someone you know, has or may have used the affected product, or suffered an adverse reaction or unexpected side-effect after use, you are advised to seek immediate medical advice from a healthcare professional," it added.
The Philippine Food and Drug Administration's (FDA) has yet to respond to ABS-CBN News' request for comment on the issue.
The Philippine Food and Drug Administration's (FDA) has yet to respond to ABS-CBN News' request for comment on the issue.
RELATED VIDEO
ADVERTISEMENT
ADVERTISEMENT
